CP Pharmaceutical Group Qingdao

CP Pharmaceutical (Qingdao) is a prominent pharmaceutical company based in China and a key subsidiary of Sino Biopharmaceutical Limited. The company specializes in the development and commercialization of therapies for bone health, endocrinology, and nephrology, holding a leadership position in the Chinese active vitamin D market. Its flagship product portfolio includes widely recognized treatments such as Gailun (alfacalcidol) and Gaishi (calcitriol), which are essential for managing osteoporosis and chronic kidney disease-related mineral disorders. Operating from a major manufacturing base in Qingdao, the firm focuses on high-quality production of soft capsules and other oral dosage forms. Additionally, the company leverages its coastal location to advance the research and development of marine-derived pharmaceuticals.